[Fibromyalgia in the new era of SARS-CoV-2 infection and post-COVID-19 syndrome: A scoping review].

ABSTRACT:

Introduction

Fibromyalgia is a syndrome characterized by chronic generalized pain, joint stiffness, sleep disorders, fatigue, anxiety and depressive episodes, whose clinical manifestations begin after a physical or emotional trauma. However, few publications describe the clinical impact of COVID-19 on fibromyalgia symptoms.

Objective

To map the available medical evidence on the impact of COVID-19 and PCS in patients with and without a diagnosis of fibromyalgia prior to infection.

Materials and methods

Exploratory systematic review in PubMed and Scopus, considering articles in English and Spanish, with data on fibromyalgia in the population surviving SARS-CoV-2 infection. The clinical trial records of the World Health Organization databases were reviewed.

Results

SUBMITTER: Tuta-Quintero E 

PROVIDER: S-EPMC9061136 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature